What Do Peer Reviewers Look For? The Actual Criteria by Journal Tier (2026)

Peer reviewer criteria differ meaningfully based on where a journal sits in the tier hierarchy. Here is what each tier actually evaluates, based on official reviewer guidelines and patterns from 750+ journal-specific desk-rejection and reviewer feedback records.

Tier 1: High-impact journals (Nature, Cell, Science, NEJM, Lancet, IF 30+)

Reviewers here are gatekeeping one thing above all else: is this paper going to change how people think about the field?

At Nature, manuscripts are rejected outright "on grounds of specialist interest, lack of novelty, or insufficient conceptual advance" before reviewers even assess the methodology in detail. If the paper passes that significance threshold, reviewers then verify that the evidence is strong enough to support the claims. Technical rigor is assumed, not the primary question.

Cell Press reviewers are asked explicitly whether the paper "establishes a new principle or describes a variation on known biology." The distinction matters. Variation on known biology gets rejected. New principle gets reviewed seriously.

At NEJM, the operating bar is clinical immediacy: the paper must present evidence that could change what a practicing clinician does tomorrow. Not eventually. Not in principle. Tomorrow.

What this means in practice: At this tier, underselling your contribution is a common and expensive mistake. A hedged "may contribute to" abstract at a Nature-tier journal reads as insufficient advance. The reviewers are asking themselves a single question: why does this matter now? Your paper needs to answer it in the first paragraph.

Named failure pattern: A paper submitted to Nature that presents a mechanistic finding as "building toward" a therapeutic application rather than as a complete mechanistic insight will struggle. The reviewers don't want the building-toward version. They want the complete mechanistic insight, even if therapeutic application is years away.

Tier 2: Mid-tier disciplinary journals (IF 5-15)

At journals in this range, the significance question is still relevant, but it no longer automatically dominates the review. Reviewers spend most of their report on methodology.

PMC research on rejection reasons at mid-tier journals documents that methodological concerns including inadequate controls, weak statistical analysis, and conclusions outrunning the data account for the majority of post-peer-review rejections in this tier. Novelty concerns are more common at desk rejection but less dominant in reviewer reports.

Elsevier's structured reviewer guidelines for this tier explicitly ask reviewers to evaluate whether statistical methods are appropriate and well described, whether conclusions are appropriately supported, and whether the literature section identifies key citations or leaves them missing.

What this means in practice: Your paper can be well-motivated and genuinely novel and still get rejected because a reviewer's report focuses on your sample size justification, your choice of statistical test, or the absence of a control condition. These aren't gatekeeping questions at Nature. At IF 10, they are.

Named failure pattern: In our pre-submission review work with manuscripts targeting mid-tier clinical and biomedical journals, the most consistent post-review rejection trigger is conclusions that outrun the data. The abstract claims X. The results show a trend toward X with a borderline p-value. A reviewer with a methods lens catches that immediately. The fix isn't to downgrade the conclusion after rejection. It's to align the abstract and results section before submission.

Tier 3: Megajournals and open-access broad journals (PLOS ONE, Scientific Reports, IF 2-5)

This tier has the clearest documented standard, and it's also the one most misunderstood by researchers submitting for the first time.

PLOS ONE explicitly instructs reviewers that "the journal does not use peer review to determine whether research reaches a threshold of importance" and that "ground-breaking significance is not required for publication." Reviewers are asked to evaluate seven criteria, all of which are soundness-based: original results, not published elsewhere, technically performed to a high standard, conclusions supported by data, written in standard English, meeting ethics standards, adhering to reporting guidelines.

Novelty is not on the list. Trying to impress PLOS ONE reviewers with an impact argument wastes space and can read as trying to paper over methodological gaps.

Named failure pattern: Papers submitted to PLOS ONE that spend two paragraphs in the introduction establishing novelty, then arrive at a Methods section that doesn't fully describe the statistical approach or omit reporting guidelines compliance, are rejected on exactly the criteria that would have been fixable with one extra pass. The reviewer doesn't care about the impact argument. They do care that your CONSORT checklist is complete.

Across all tiers, three things matter regardless of journal:

1. Conclusions match evidence. Every tier, every reviewer. The abstract's claims have to be supported by the actual data. This is the single most consistent rejection reason documented in the peer review literature, from PMC studies of rejection reports to Elsevier's structured reviewer forms.

2. Methods are reproducible. Can another lab repeat this? Reviewers at every tier check whether the methodology section contains enough detail to replicate the work. This is a baseline expectation, not an advanced criterion.

3. The paper is in scope. Scope mismatch at the desk is so common it barely qualifies as peer review feedback, but scope misread still shows up in reviewer reports. A reviewer who has to spend time explaining that your work belongs in a different journal is not giving you useful revision guidance.

Sites like Enago and AJE list the same five criteria: significance, methodology, novelty, ethics, writing quality. That list is accurate for an average across all journals. It is not useful for any specific journal.

The gap: if you're submitting to a Nature-tier journal, "methodology" is table stakes. If you're submitting to PLOS ONE, "significance" is irrelevant. Treating the list as universal leads researchers to either over-invest in significance arguments where reviewers don't care, or under-invest in methodological detail where reviewers scrutinize it hardest.

What do peer reviewers look for in a manuscript?

It depends on the journal tier. At Nature, Cell, and NEJM, reviewers evaluate significance and conceptual advance first. At journals with IF 5-10, methodology and rigor take center stage. At PLOS ONE, reviewers evaluate technical soundness only and are explicitly instructed not to consider novelty. Most generic advice conflates these into one list, which leads researchers to oversell novelty to methodological journals or undersell it to high-impact ones.

What is the most common reason peer reviewers reject manuscripts?

At high-impact journals, insufficient novelty or conceptual advance is the leading rejection reason. At mid-tier journals, methodological concerns dominate: inadequate controls, weak statistical analysis, or conclusions that outrun the data. At megajournals like PLOS ONE, scope mismatch and ethics compliance are more common grounds than scientific novelty.

Do peer reviewers check for plagiarism?

Not directly. Plagiarism screening is automated by journal submission systems before papers reach reviewers. Reviewers do flag self-plagiarism and text recycling when they recognize it, and they may raise concerns about undisclosed overlap with prior work. But the primary plagiarism check is a software gate, not a reviewer responsibility.

How long does peer review take?

Median peer review times range from 4 weeks at fast-turnaround journals to 3-4 months at major disciplinary journals. Nature and Cell tend to move faster than their prestige might suggest (8-12 weeks from submission to first decision). Specialty journals are often slower. SciRev community data shows wide variation even within the same journal.

Can I find out what reviewers said before submitting?

Indirectly, yes. SciRev.sc collects author-reported review experiences including common feedback themes. PubPeer hosts post-publication reviewer-style comments. For journals that use open review (eLife, some PLOS titles), published reviewer reports are publicly accessible. Manusights synthesizes patterns from 750+ journal-specific desk-rejection and reviewer feedback records to flag likely reviewer concerns before you submit.

For journal-specific desk rejection patterns, see desk rejection rates by journal and the how to avoid desk rejection guide.